Summary
Updated Aug 31, 2026
Francis E. Odonnell Jr. is Chief Executive Officer, Director, 10% Owner of Inhibitor Therapeutics, Inc. (INTI). 1 SEC Form 4 filing on record, dated 4 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Francis E. Odonnell Jr. has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Francis E. Odonnell Jr.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Paul B. Manning - $31.74M of LQDA open-market activity in the last 12 months
- LILLY ENDOWMENT INC - $3.10B of LLY open-market activity in the last 12 months
- KKR Phoenix Aggregator L.P. - $2.09B of BTSG open-market activity in the last 12 months
- KKR Group Partnership L.P. - $2.09B of BTSG open-market activity in the last 12 months
- WARBURG PINCUS CO. - $1.30B of SHC open-market activity in the last 12 months
- GTCR INVESTMENT XI LLC - $760.39M of SHC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Francis E. Odonnell Jr.?
Francis E. Odonnell Jr. is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of Inhibitor Therapeutics, Inc. (INTI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Francis E. Odonnell Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Francis E. Odonnell Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Francis E. Odonnell Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
